EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Design, Synthesis, Antimicrobial Activity, and Molecular Docking of Novel Thiazoles, Pyrazoles, 1,3-Thiazepinones, and 1,2,4-Triazolopyrimidines Derived from Quinoline-Pyrido[2,3-d] Pyrimidinones

Ameen Ali Abu-Hashem iD, Sami A Al-Hussain

Pharmaceuticals · 04.12.2024 · 17 (12) · 1632

DOI: 10.3390/ph17121632 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pharmaceuticals, online erschienen am 04.12.2024. Verfasst von Ameen Ali Abu-Hashem und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physical Sciences, Chemistry Division, College of Science, Jazan University, Jazan 45142, Saudi Arabia. Die Arbeit wurde bisher 49-mal zitiert (Crossref) und nennt 91 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Recently, pyrido[2,3-d] pyrimidine, triazolopyrimidine, thiazolopyrimidine, quinoline, and pyrazole derivatives have gained attention due to their diverse biological activities, including antimicrobial, antioxidant, antitubercular, antitumor, anti-inflammatory, and antiviral effects.

Objective

The synthesis of new heterocyclic compounds including 5-quinoline-pyrido[2,3-d] pyrimidinone (1–2, 4, 6–7), 6-quinoline-pyrido[2,3-d]thiazolo[3,2-a]pyrimidinone (3, 5, 8–10), 1,2,4-triazole-6-quinoline-pyrido[2,3-d]thiazolo[3,2-a]pyrimidinone (11–13), and pyrido[2,3-d]thiazolo[3,2-a]pyrimidine-ethyl-(pyridine)-9-thiaazabenzo[cd]azulenone (14) derivatives was performed with high yields while evaluating antimicrobial activities.

Methods

A new series of quinoline-pyrido[2,3-d]thiazolo[3,2-a]pyrimidine derivatives were prepared using a modern style and advanced technology, resulting in high yields of these new compounds. Various reagents were utilized, specifically tailored to the production needs of each compound, through reactions that included alkylation, addition, condensation, acylation, the formation of Schiff bases, and intramolecular cyclization.

Results

The chemical structures of the new compounds were determined using spectroscopy analyses, including IR, NMR, and MS, achieving good yields ranging from 68% to 90% under mild conditions in a regular system. All compounds were tested for in vitro antimicrobial activity and compared to standard drugs, specifically cefotaxime sodium and nystatin. The results showed that compounds 10 to 14 exhibited excellent antimicrobial activity, with a minimum inhibitory concentration (MIC) of 1 to 5 µmol/mL, compared to that of the standard drugs, which had MIC values of 1 to 3 µmol/mL. Furthermore, molecular docking studies were conducted to explore the interactions of specific compounds with antimicrobial target proteins. The findings revealed that compounds 10 to 14 displayed significant binding energies, with ΔG values ranging from −7.20 to −11.70 kcal/mol, indicating effective binding to the active sites of antimicrobial protein receptors.

Conclusions

The SAR study confirmed a relationship between antimicrobial activity and the tested compounds. Molecular docking demonstrated that compounds 10, 11, 12, 13, and 14 exhibited significant binding energy, effectively interacting with the active sites of antimicrobial protein receptors. This consistent finding supports that these new compounds’ practical and theoretical studies align regarding their antimicrobial activity.

Schlagwörter

Stichwörter der Autor:innen

1,2,4-triazolopyrimidine1,3-thiazepinoneantimicrobial activityhydrazinemolecular dockingpyrazolepyrido[2,3-d] pyrimidinepyridothiazolopyrimidinonequinolinethiazole

Autor:innen und Institutionen

  • Department of Physical Sciences, Chemistry Division, College of Science, Jazan University, Jazan 45142, Saudi Arabia.
  • Department of Chemistry, Faculty of Science, Imam Mohammad Ibn Saud Islamic University (IMSIU), Riyadh 11623, Saudi Arabia.

ORCID-Profile: Ameen Ali Abu-Hashem

Zitieren

APA

Abu-Hashem, A. A., & Al-Hussain, S. A. (2024). Design, Synthesis, Antimicrobial Activity, and Molecular Docking of Novel Thiazoles, Pyrazoles, 1,3-Thiazepinones, and 1,2,4-Triazolopyrimidines Derived from Quinoline-Pyrido[2,3-d] Pyrimidinones. Pharmaceuticals, 17(12), 1632. https://doi.org/10.3390/ph17121632

Vancouver

Abu-Hashem AA, Al-Hussain SA. Design, Synthesis, Antimicrobial Activity, and Molecular Docking of Novel Thiazoles, Pyrazoles, 1,3-Thiazepinones, and 1,2,4-Triazolopyrimidines Derived from Quinoline-Pyrido[2,3-d] Pyrimidinones. Pharmaceuticals. 2024;17(12):1632. doi:10.3390/ph17121632

BibTeX
@article{AbuHashem2024,
  author = {Abu-Hashem, Ameen Ali and Al-Hussain, Sami A},
  title = {Design, Synthesis, Antimicrobial Activity, and Molecular Docking of Novel Thiazoles, Pyrazoles, 1,3-Thiazepinones, and 1,2,4-Triazolopyrimidines Derived from Quinoline-Pyrido[2,3-d] Pyrimidinones},
  journal = {Pharmaceuticals},
  year = {2024},
  volume = {17},
  number = {12},
  pages = {1632},
  doi = {10.3390/ph17121632}
}
Kostenlos starten →